Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase NA 3Phase 2 2Phase 3 1Phase 1/2 1

Status

Completed 94Unknown 19Terminated 13Active not recruiting 11Recruiting 10Withdrawn 5Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Neoplasms 2Leukemia 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Tissue Adhesions 1Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Pain, Intractable 1Ovarian Neoplasms 1Ovarian Cysts 1Neurotoxicity Syndromes 1Neoplasm Metastasis 1NSCLC 1Multiple Myeloma 1Mucositis 1Malnutrition 1Malignant Female Reproductive System Neoplasm 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Glioblastoma 1Fatigue 1Fasting Mimicking Diet 1Eyelid Squamous Cell Carcinoma 1Endometriosis 1

Interventions

Prednisolone 1Methylprednisolone 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Suspended × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Clear all
NCT00991744 2012-10-10

Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)

Nordic Society for Pediatric Hematology and Oncology

Phase 3 Suspended
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Neurotoxicity Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡